Enervit Logo

Enervit

Develops sports nutrition, functional foods, and wellness supplements.

ENV | XMIL

Overview

Corporate Details

ISIN(s):
IT0004356751
LEI:
8156002B06C3A4C0F436
Country:
Italy
Address:
VIALE PAPA ACHILLE, 30, 20149 MILANO

Description

Enervit is a company specializing in the research, development, and production of sports nutrition, functional foods, and innovative supplements. Operating with a fully in-house approach, it formulates and manufactures a comprehensive range of products designed to support athletic performance, fitness, and general well-being. The product portfolio includes energy gels, bars, sports drinks, protein-rich shakes, and specialized supplements. Enervit serves a diverse market, including professional athletes in endurance, strength, and team sports, as well as fitness enthusiasts and health-conscious individuals. The company offers distinct product lines: one for sports and active lifestyles, and another for balance and wellness, featuring products based on the 40-30-30 Zone diet principles and Omega-3 supplements. This approach is guided by a philosophy of 'Positive Nutrition,' which emphasizes scientific innovation to meet diverse nutritional needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-05-23 16:28
CS-Deposito Verbale Assemblea Ordinaria 2024
Italian PDF 183.5 KB
2024-05-08 13:06
CS Dati Trimestrali Vendite al 31 marzo 2024
Italian PDF 279.7 KB
2024-04-23 13:20
Rendiconto Sintetico Votazioni
Italian PDF 129.4 KB
2024-04-23 13:17
AVVISO pagamento dividendo esercizio 2023
Italian PDF 579.9 KB
2024-04-23 13:16
CS - Assemblea ordinaria azionisti Enervit
Italian PDF 253.9 KB
2024-04-02 13:06
AVVISO - messa a disposizione rel. fin. annuale
Italian PDF 578.4 KB
2024-04-02 13:04
CS - Documentazione messa a disposizione del pubblico
Italian PDF 145.5 KB
2024-04-02 12:58
Relazione Governo Societario Ass 2024 esercizio 2023
Italian PDF 1.0 MB
2024-04-02 12:57
Relazione sulla Remunerazione
Italian PDF 677.5 KB
2024-03-14 14:30
Relazione illustrativa materie all'ordine del giorno Assemblea 2024
Italian PDF 274.6 KB
2024-03-14 14:27
DELEGA Rappres. Designato Undecies
Italian PDF 415.9 KB
2024-03-14 14:26
DELEGA Rappres. Designato Novies
Italian PDF 373.2 KB
2024-03-14 14:23
ESTRATTO di avviso convocazione ASSEMBLEA 2024
Italian PDF 1.2 MB
2024-03-14 14:22
AVVISO di convocazione ASSEMBLEA 2024
Italian PDF 205.1 KB
2024-03-14 14:19
CS post CDA 14.03.2024
English PDF 470.7 KB

Automate Your Workflow. Get a real-time feed of all Enervit filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enervit

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enervit via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.